Temporary treatment with sirolimus and low-trough cyclosporine prevents acute islet allograft rejection, and combination with starch-conjugated deferoxamine promotes islet engraftment in the preclinical pig model

Transplant Proc. 2001 Feb-Mar;33(1-2):509. doi: 10.1016/s0041-1345(00)02114-x.
No abstract available

MeSH terms

  • Acute Disease
  • Animals
  • Chelating Agents / therapeutic use*
  • Cyclosporine / therapeutic use
  • Deferoxamine / therapeutic use*
  • Drug Therapy, Combination
  • Graft Rejection / prevention & control*
  • Graft Survival / drug effects*
  • Immunosuppressive Agents / therapeutic use*
  • Islets of Langerhans Transplantation / immunology*
  • Sirolimus / therapeutic use
  • Swine
  • Transplantation, Homologous

Substances

  • Chelating Agents
  • Immunosuppressive Agents
  • Cyclosporine
  • Deferoxamine
  • Sirolimus